» Articles » PMID: 39472332

Nanoplasmonic Microarray-based Solid-phase Amplification for Highly Sensitive and Multiplexed Molecular Diagnostics: Application for Detecting SARS-CoV-2

Overview
Journal Mikrochim Acta
Specialties Biotechnology
Chemistry
Date 2024 Oct 30
PMID 39472332
Authors
Affiliations
Soon will be listed here.
Abstract

A novel approach is introduced using nanoplasmonic microarray-based solid-phase recombinase polymerase amplification (RPA) that offers high sensitivity and multiplexing capabilities for gene detection. Nanoplasmonic microarrays were developed through one-step immobilization of streptavidin/biotin primers and fine-tuning the amplicon size to achieve high plasmon-enhanced fluorescence (PEF) on the nanoplasmonic substrate, thereby improving sensitivity. The specificity and sensitivity of solid-phase RPA on nanoplasmonic microarrays was evaluated in detecting E, N, and RdRP genes of SARS-CoV-2. High specificity was achieved by minimizing primer-dimer formation and employing a stringent washing process and high sensitivity obtained with a limit of detection of four copies per reaction within 30 min. In clinical testing with nasopharyngeal swab samples (n = 30), the nanoplasmonic microarrays demonstrated a 100% consistency with the PCR results for detecting SARS-CoV-2, including differentiation of Omicron mutations BA.1 and BA.2. This approach overcomes the sensitivity issue of solid-phase amplification, as well as offers rapidity, high multiplexing capabilities, and simplified equipment by using isothermal reaction, making it a valuable tool for on-site molecular diagnostics.

References
1.
Qin X, Paul R, Zhou Y, Wu Y, Cheng X, Liu Y . Multiplex solid-phase RPA coupled CRISPR-based visual detection of SARS-CoV-2. Biosens Bioelectron X. 2024; 14. PMC: 10827331. DOI: 10.1016/j.biosx.2023.100381. View

2.
Ichzan A, Hwang S, Cho H, Fang C, Park S, Kim G . Solid-phase recombinase polymerase amplification using an extremely low concentration of a solution primer for sensitive electrochemical detection of hepatitis B viral DNA. Biosens Bioelectron. 2021; 179:113065. DOI: 10.1016/j.bios.2021.113065. View

3.
Bednar M . DNA microarray technology and application. Med Sci Monit. 2001; 6(4):796-800. View

4.
Kim K, Ryu E, Khaleel Z, Seo S, Kim L, Kim Y . Plasmonic digital PCR for discriminative detection of SARS-CoV-2 variants. Biosens Bioelectron. 2023; 246:115859. DOI: 10.1016/j.bios.2023.115859. View

5.
Purohit S, Sharma A, She J . Luminex and other multiplex high throughput technologies for the identification of, and host response to, environmental triggers of type 1 diabetes. Biomed Res Int. 2015; 2015:326918. PMC: 4389818. DOI: 10.1155/2015/326918. View